The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months. (sciencedaily.com)
«This is an important initiative — to test new drugs, being developed for other types of cancers in the laboratory to identify which are most promising for testing in patients with glioblastoma. (sciencedaily.com)
«This finding suggests a novel therapeutic target to decrease invasion of tumor cells in patients and may also provide a novel biomarker that could help predict survival of patients with glioblastoma,» explained Israel. (sciencedaily.com)